(SNDX) |
| 0 (0%) 10-10 19:07 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 19.95 |
| Resistance 1: | 17.08 |
| Pivot price: | 15.65 |
| Support 1: | 15.50 |
| Support 2: | 14.53 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -3.890 |
| Book Value | 1.830 |
| PEG Ratio | 0.00 |
| Gross Profit | -2.153 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -182.71 |
| Return on Assets (ttm) | -39.5 |
| Return on Equity (ttm) | -113.2 |
Company news
Thu, 09 Oct 2025
How buybacks impact SNDX stock value - July 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Thu, 09 Oct 2025
Syndax Pharmaceuticals (NASDAQ:SNDX) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Tue, 07 Oct 2025
Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer - AOL.com
Mon, 06 Oct 2025
Syndax Pharmaceuticals (SNDX): Valuation in Focus After Revumenib Wins Key NCCN Recommendation and Priority FDA Review - simplywall.st
Mon, 06 Oct 2025
Research Analysts Offer Predictions for SNDX FY2027 Earnings - MarketBeat
Fri, 03 Oct 2025
138,900-Share Grant: Syndax Awards to 10 New Employees; Options Vest Monthly Under Inducement Plan - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
